Flurazine 5 mg, a medication that belongs to the class of anti-vertigo drugs. It is known for its ability to inhibit calcium influx into neuronal cells, which helps reduce the frequency of all forms of migraine attacks.

Flurazine 5 mg is considered a preferred option for many patients due to its effectiveness and safety when used under medical supervision to ensure the optimal dosage and avoid any potential side effects.

Each capsule of Flurazine 5 mg contains 5 mg Flunarizine HCl.

Flurazine 5 mg is mainly used in the treatment of dizziness, vertigo.

Flurazine 5 mg is effective in reducing attack of migraine but is particularly effective in migraine with severe and disabling neurological symptoms (for instance, migraine with aura or without aura).

Elderly:

Flurazine 5 mg is given to elderly people after adjusting the dose.

Children:

The safety and efficacy of Flurazine 5 mg in the prophylaxis of migraine has not been established in patients younger than 18 years of age.

Pregnancy& breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking Flurazine 5 mg.

Pregnancy Category: N (Not Classified).

Flurazine 5 mg should not be used whilst breastfeeding because of small amounts Flurazine 5 mg appear in breast milk.

Adults (Under 65 years of age):

Flurazine 5 mg should be taken at night-time starting with a low dose. This may then be increased as recommended by the doctor.

The recommended dose of Flurazine 5 mg is tow capsules (10 mg) daily.

If, during this treatment, depressive, extrapyramidal or other unacceptable adverse experiences occur, administration should be discontinued.

If, after 3 months of this initial treatment, no significant improvement is observed, the patient should be considered a non-responder and administration should also be discontinued.

Elderly (65 Years of age and over):

The recommended dose of Flurazine 5 mg is one capsule at night-time.

clinical experience suggests that 2 successive drug-free days per week may decrease the potential for adverse reactions.